Garheng Kong - Profile and Investment Details

Investor Profile

Garheng Kong is a Venture Capital, Private Equity Firm, Investor based in United States with a diverse investment portfolio that includes companies such as Magnolia Medical Technologies, Avizia, RareCyte, inMediata, Bardy Diagnostics, Springbuk, Spirox, Alcresta, Pulmonx, Vestagen Technical Textiles, Harmony Home Health, Venus Concept, Biotheranostics, Trice Medical, Lineagen, First Aid Shot Therapy, EverlyWell, PerspectumCleanSlate Centers, Ajax Health, Castle Biosciences, TigerConnect, BioIQ, Avedro, . Over time, Garheng Kong has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Garheng Kong is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Cybersecurity, Messaging, Wellness, Women Founded, Enterprise Software, Recruitment, Healthcare Innovation, Education, Mobile, Biotechnology, Consumer Health, Cosmetics, Health and Hospital Services, Productivity Software, Legal Tech, Clinical Trials, FinTech, Natural Language Processing, Health Diagnostics, Digital Health, Job Recruitment, Medical, B2B, Emergency Medicine, Healthcare Technology, Medical Documentation may find it worthwhile to explore potential connections with Garheng Kong, as their portfolio suggests a familiarity and interest in this area.

Understanding Garheng Kong’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.